Rofecoxib

DRUG12 trials

Sponsors

National Institute on Aging (NIA), National Institute of Dental and Craniofacial Research (NIDCR), Cancer Research Campaign Clinical Trials Centre, Merck Sharp & Dohme LLC, Sheba Medical Center

Conditions

Acute PainAdvanced Non-small Cell Lung CancerAlzheimer DiseaseAntiphospholipid Antibody SyndromeBarrett's EsophagusColorectal CancerDuodenal PolyposisHeadache

Phase 2

A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)

CompletedNCT00004845

National Institute on Aging (NIA)Alzheimer Disease

End: 2001-12-31Updated: 2009-12-11

Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction

CompletedNCT00026819

National Institute of Dental and Craniofacial Research (NIDCR)Pain

Start: 2001-11-30End: 2003-11-30Target: 150Updated: 2008-03-04

Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

CompletedNCT00385606

National Cancer Institute, NaplesAdvanced Non-small Cell Lung Cancer

Start: 2003-01-31End: 2006-07-31Updated: 2023-03-23

Coxib-inhibition of Duodenal Polyp Growth in FAP

TerminatedNCT00844727

Oslo University HospitalDuodenal Polyposis

Start: 2003-09-30End: 2004-04-30Updated: 2011-07-06

Phase 3

Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer

CompletedNCT00031863

Cancer Research Campaign Clinical Trials CentreColorectal Cancer

Start: 2001-02-28End: 2007-09-30Updated: 2013-08-02

Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)

CompletedNCT00060476

Merck Sharp & Dohme LLCProstate Cancer

Start: 2003-01-08End: 2004-12-08Updated: 2017-05-09

A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee

CompletedNCT00568295

Johnson & Johnson Consumer and Personal Products WorldwideOsteoarthritis of the Knee

Start: 1999-10-31End: 2000-10-31Updated: 2011-08-22

Safety of Lumiracoxib in Patients With Osteoarthritis

CompletedNCT00637949

NovartisOsteoarthritis

Start: 2000-12-31End: 2001-03-31Updated: 2008-03-18

Phase 4

Barrett's Esophagus - 315 - 3 Way Cross Over

CompletedNCT00637988

AstraZenecaBarrett's Esophagus

Start: 2002-04-30End: 2003-06-30Target: 32Updated: 2011-01-21

A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain

TerminatedNCT00657449

PfizerAcute Pain

Start: 2003-06-04End: 2004-10-05Updated: 2018-11-30

Unknown Phase

An End to the Yom Kippur (and Ramadan) Headache

CompletedNCT00263094

Sheba Medical CenterHeadache

Start: 2004-09-30End: 2004-11-30Target: 220Updated: 2006-01-27

CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen

CompletedNCT01762891

Hospital Universitario Pedro ErnestoAntiphospholipid Antibody Syndrome

Start: 2003-03-31End: 2009-09-30Updated: 2013-01-08

Related Papers

The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.

2011-12-1447 citations

A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.

2008-09-086 citations